An Open-Label, Phase 1/1B, Single-Agent Study of RXDX-105 In Patients With Advanced Solid Tumors - Regional Cancer Care Associates LLC

Clinical Trials

An Open-Label, Phase 1/1B, Single-Agent Study of RXDX-105 In Patients With Advanced Solid Tumors

Type of Cancer
Solid Tumor
Locations
Bethesda
Sponsor
Ignyta, Inc.
Protocol Number
RXDX-105-01
Cancer Diagnosis
To Learn More Call
201-510-0910